000 | 01948 a2200553 4500 | ||
---|---|---|---|
005 | 20250517183432.0 | ||
264 | 0 | _c20181211 | |
008 | 201812s 0 0 eng d | ||
022 | _a1873-7544 | ||
024 | 7 |
_a10.1016/j.neuroscience.2017.10.038 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNi, Yong | |
245 | 0 | 0 |
_aRIP1K Contributes to Neuronal and Astrocytic Cell Death in Ischemic Stroke via Activating Autophagic-lysosomal Pathway. _h[electronic resource] |
260 |
_bNeuroscience _c02 2018 |
||
300 |
_a60-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAstrocytes _xdrug effects |
650 | 0 | 4 |
_aAutophagy _xdrug effects |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
650 | 0 | 4 |
_aCell Hypoxia _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aGTPase-Activating Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aGlucose _xdeficiency |
650 | 0 | 4 |
_aLysosomes _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice, Inbred ICR |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aReceptor-Interacting Protein Serine-Threonine Kinases |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aStroke _xdrug therapy |
700 | 1 | _aGu, Wei-Wei | |
700 | 1 | _aLiu, Zhi-He | |
700 | 1 | _aZhu, Yong-Ming | |
700 | 1 | _aRong, Jia-Guo | |
700 | 1 | _aKent, Thomas A | |
700 | 1 | _aLi, Min | |
700 | 1 | _aQiao, Shi-Gang | |
700 | 1 | _aAn, Jian-Zhong | |
700 | 1 | _aZhang, Hui-Ling | |
773 | 0 |
_tNeuroscience _gvol. 371 _gp. 60-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2017.10.038 _zAvailable from publisher's website |
999 |
_c27753746 _d27753746 |